Contact UsInvestorsCareersMediaScienceContact Us
Battling Cancer:
At the Speed of Science

One in five people will receive a diagnosis of cancer within their lifetime.
That is why nothing is more personal, or more urgent, than our goal to find cures for these deadly diseases.

HomeScienceAreas of FocusOncology

Types of Cancers

Over the past decade, we’ve taken bold new approaches to translate scientific research into effective medicines for people living with cancer. Now, we’re working tirelessly to develop a new generation of breakthroughs across multiple cancers and tumor types.
Worldwide, breast cancer is the most common invasive cancer, with more than 2.2 million impacted annually. Metastatic breast cancer (mBC), the most advanced stage of breast cancer in which the cancer has spread beyond the breast to other parts of the body (i.e., organs, bones), remains an incurable disease. As a result of earlier screening, increased awareness, and better treatments, breast cancer deaths have continued to decrease in older women. From 2013 to 2018, the death rate went down by 1% per year.
Lung cancer remains the leading cause of cancer-related death among men and women globally, and the global five-year survival rate at 17.8 percent is much lower than leading cancers. Lung cancer is notoriously difficult to treat due to the heterogeneous nature of the disease, variability in testing rates and the onset of drug resistance. These challenges necessitate an individualized approach to treatment, ensuring people with lung cancer receive the right drug at the right time.
The genitourinary (GU) tract is comprised of urinary, reproductive and adrenal system organs. Organs of the genitourinary tract include the prostate (males only), kidneys and bladder. GU cancers are pervasive and notoriously hard to treat, despite available therapies. Each person’s cancer behaves differently, requiring a tailored, individualized approach for each individual.
Blood cancers strike ruthlessly at any age. Some come fast and take lives within weeks or months. Others develop in the bones and blood over time, requiring intense and aggressive treatment interventions that are traumatic, emotionally overwhelming, and expensive. More than 1 million people worldwide were diagnosed with a blood cancer in 2020, representing almost 6% of all cancer diagnoses globally. In 2020, more than 700,000 people worldwide died from a form of blood cancer.

The science of optimism

View All Oncology

Preventing the spread of infections

View All Vaccines
Anti Infectives

Combatting an evolving risk

View All Anti Infectives
Inflammation & Immunology

Treatment at the molecular level

View All Inflammation & Immunology
Rare Disease

Smaller populations but big impact 

View All Rare Disease
Pipeline Publicity of Medical RepresentativesPfizer Medical Information PfizerPro for Professionals Grant Seekers Media Terms of UseContact Us Business to Business © 2022 Pfizer Inc. All rights reserved 沪公网安备31010602006040 沪ICP备11000910号-2 药监批号(沪)-非经营性-2016-0003